Novel multitarget ligands against Alzheimer's disease have been developed. The new hybrids have been obtained by fusing tacrines with resveratrol. The most interesting hybrids inhibited hAChE and modulated Aβ self-aggregation. Hybrid 12 showed a low neurotoxicity and neuroprotective effect on neuroinflammation.